| Literature DB >> 28350989 |
Haibo Wang1, Ana Lis Moyano2, Zhangyan Ma1, Yaqi Deng1, Yifeng Lin3, Chuntao Zhao1, Liguo Zhang1, Minqing Jiang1, Xuelian He1, Zhixing Ma1, Fanghui Lu1, Mei Xin1, Wenhao Zhou3, Sung Ok Yoon4, Ernesto R Bongarzone2, Q Richard Lu5.
Abstract
A lack of sufficient oligodendrocyte myelination contributes to remyelination failure in demyelinating disorders. miRNAs have been implicated in oligodendrogenesis; however, their functions in myelin regeneration remained elusive. Through developmentally regulated targeted mutagenesis, we demonstrate that miR-219 alleles are critical for CNS myelination and remyelination after injury. Further deletion of miR-338 exacerbates the miR-219 mutant hypomyelination phenotype. Conversely, miR-219 overexpression promotes precocious oligodendrocyte maturation and regeneration processes in transgenic mice. Integrated transcriptome profiling and biotin-affinity miRNA pull-down approaches reveal stage-specific miR-219 targets in oligodendrocytes and further uncover a novel network for miR-219 targeting of differentiation inhibitors including Lingo1 and Etv5. Inhibition of Lingo1 and Etv5 partially rescues differentiation defects of miR-219-deficient oligodendrocyte precursors. Furthermore, miR-219 mimics enhance myelin restoration following lysolecithin-induced demyelination as well as experimental autoimmune encephalomyelitis, principal animal models of multiple sclerosis. Together, our findings identify context-specific miRNA-regulated checkpoints that control myelinogenesis and a therapeutic role for miR-219 in CNS myelin repair.Entities:
Keywords: Etv5; Lingo1; demyelinating injury; experimental autoimmune encephalomyelitis; gene regulatory network; miR-219; miR-338; microRNAs; myelination; remyelination
Mesh:
Substances:
Year: 2017 PMID: 28350989 PMCID: PMC5569304 DOI: 10.1016/j.devcel.2017.03.001
Source DB: PubMed Journal: Dev Cell ISSN: 1534-5807 Impact factor: 12.270